Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-01

Clinical Trial Update: Bicarbonate v Saline to Prevent Contrast Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bicarbonate versus saline to prevent contrast-induced nephropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Normal Saline (0.9% Sodium Chloride) (sodium chloride)
  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Italian Society of Nephrology | Conditions: Kidney Failure, Acute, Contrast Media | Phase 4 | Status: TERMINATED